Vertebral fracture risk reduction over two years with risedronate 35 mg once-a-week

被引：0
|
作者：
Watts, NB
Lindsay, R
Li, Z
Brown, J
机构：
[1] Univ Cincinnati, Bone Hlth & Osteoporosis Ctr, Cincinnati, OH USA
[2] Helen Hayes Hosp, Reg Bone Ctr, W Haverstraw, NY USA
[3] Procter & Gamble Pharmaceut, Cincinnati, OH USA
[4] CHUQ, Ctr Rech, Quebec City, PQ, Canada
来源：
OSTEOPOROSIS INTERNATIONAL | 2002年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P82
引用
收藏
页码：S40 / S40
页数：1
相关论文
共 50 条
  • [11] Risedronate 35 mg once a week is as effective as 5 mg daily in postmenopausal women.
    Lindsay, R
    Kendler, D
    McClung, MR
    Balske, A
    Li, ZQ
    Brown, J
    [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S153 - S153
  • [12] A NOVEL DELAYED-RELEASE RISEDRONATE 35 MG ONCE-A-WEEK FORMULATION TAKEN WITH OR WITHOUT BREAKFAST: 2-YEAR BMD DATA
    Benhamou, Claude-Laurent
    Zanchetta, Jose
    Kaufman, Jean-Marc
    Brown, Jacques
    Maasalu, Katre
    Lakatos, Peter
    Badurski, Janusz
    Wenderoth, Dietrich
    McClung, Michael
    [J]. OSTEOPOROSIS INTERNATIONAL, 2011, 22 : 337 - 338
  • [13] Sustained fracture risk reduction over 5 years with risedronate therapy.
    Watts, NB
    Brown, J
    Hosking, D
    Adami, S
    Mulder, H
    Reginster, JY
    Kasibhatla, C
    Chines, A
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S217 - S217
  • [14] Reduction in vertebral fracture risk persists after discontinuation of risedronate
    不详
    [J]. Nature Clinical Practice Endocrinology & Metabolism, 2008, 4 (6): : 307 - 307
  • [15] Risedronate treatment produces a significant reduction in the risk of clinical vertebral fractures over 3 years
    不详
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2006, 78 : S129 - S129
  • [16] Risedronate treatment produces a significant reduction in the risk of clinical vertebral fractures over 3 years.
    Adachi, J. D.
    Klemes, A. B.
    Zhou, X.
    Boonen, S.
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S82 - S82
  • [17] RisedronatE and ALendronate Intervention over Three Years (REALITY): minimal differences in fracture risk reduction
    Curtis, J. R.
    Westfall, A. O.
    Cheng, H.
    Saag, K. G.
    Delzell, E.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2009, 20 (06) : 973 - 978
  • [18] RisedronatE and ALendronate Intervention over Three Years (REALITY): minimal differences in fracture risk reduction
    J. R. Curtis
    A. O. Westfall
    H. Cheng
    K. G. Saag
    E. Delzell
    [J]. Osteoporosis International, 2009, 20 : 973 - 978
  • [19] Risedronate once a week is effective in men with osteoporosis irrespective of baseline testosterone level or prevalent vertebral fracture status
    Boonen, S.
    Orwoll, E. S.
    Wenderoth, D.
    Stoner, K. J.
    Eusebio, R.
    Delmas, P. D.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2007, 80 : S157 - S158
  • [20] Once-A-Month (OAM) Risedronate 150 mg Reduced Vertebral Fracture Risk at One Year in a Historical Control Analysis.
    Watts, N.
    Klemes, A.
    Wayner, L.
    Brown, J.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S344 - S345
12345